Development of Novel Dihydrofuro[3,4-d]pyrimidine Derivatives as HIV-1 NNRTIs to Overcome the Highly Resistant Mutant Strains F227L/V106A and K103N/Y181C.
J Med Chem
; 65(3): 2458-2470, 2022 02 10.
Article
in En
| MEDLINE
| ID: mdl-35061384
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrimidines
/
HIV-1
/
Reverse Transcriptase Inhibitors
/
Anti-HIV Agents
/
HIV Reverse Transcriptase
/
Furans
Limits:
Animals
Language:
En
Journal:
J Med Chem
Journal subject:
QUIMICA
Year:
2022
Document type:
Article